Scoping review update on somatic symptom disorder that includes additional Chinese data
Somatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms.Based on the previous work, this review aims to c...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-06-01
|
| Series: | General Psychiatry |
| Online Access: | https://gpsych.bmj.com/content/36/3/e100942.full |
| _version_ | 1797769956024123392 |
|---|---|
| author | Zheng Lu Heng Wu Ayinuer Manglike Yixiao Chen Ziming Liu Kurt Fritzsche |
| author_facet | Zheng Lu Heng Wu Ayinuer Manglike Yixiao Chen Ziming Liu Kurt Fritzsche |
| author_sort | Zheng Lu |
| collection | DOAJ |
| description | Somatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms.Based on the previous work, this review aims to comprehensively synthesise updated evidence related to SSD from recent years in English publications and, more extensively, from data published in Chinese language journals.The scoping review update was based on an earlier scoping review and included Chinese language publication data from China National Knowledge Internet (CNKI), WANFANG and WEIPU between January 2013 and May 2022 and data from PubMed, PsycINFO, and Cochrane Library between June 2020 and May 2022.Initially, 2 984 articles were identified, of which 63 full texts were included for analysis. In China, SSD is mainly applied in scientific research, but it also shows good predictive validity and clinical application potential. The mean frequency of SSD was 4.5% in the general population, 25.2% in the primary care population and 33.5% in diverse specialised care settings. Biological factors, such as brain region changes and heart rate variability, are associated with the onset of SSD. Psychological impairment related to somatic symptoms is the best predictor of prognosis. While adolescent SSD was significantly associated with family function, SSD overall is associated with an increased dysfunction of cognition and emotion, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Further research is needed on suicide risk and cultural and gender-related issues.Updating the data of Chinese language studies, our research enriches the evidence-based findings related to the topics addressed in the text sections of the SSD chapter of DSM-5. However, research gaps remain about SSD reliability, population-based prevalence, suicide risk, and cultural and gender-related issues. |
| first_indexed | 2024-03-12T21:15:35Z |
| format | Article |
| id | doaj.art-1dfb14e84aa44ccc9e126496de4754a2 |
| institution | Directory Open Access Journal |
| issn | 2517-729X |
| language | English |
| last_indexed | 2024-03-12T21:15:35Z |
| publishDate | 2023-06-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | General Psychiatry |
| spelling | doaj.art-1dfb14e84aa44ccc9e126496de4754a22023-07-29T08:50:07ZengBMJ Publishing GroupGeneral Psychiatry2517-729X2023-06-0136310.1136/gpsych-2022-100942Scoping review update on somatic symptom disorder that includes additional Chinese dataZheng Lu0Heng Wu1Ayinuer Manglike2Yixiao Chen3Ziming Liu4Kurt Fritzsche51 Department of Psychosomatic Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China1 Department of Psychosomatic Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China1 Department of Psychosomatic Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China1 Department of Psychosomatic Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China1 Department of Psychosomatic Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China2 Department of Psychosomatic Medicine and Psychotherapy, Medical Center, University of Freiburg, Freiburg, GermanySomatic symptom disorder (SSD) is a new diagnosis introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which is expected to solve the diagnostic difficulties of patients with medically unexplained symptoms.Based on the previous work, this review aims to comprehensively synthesise updated evidence related to SSD from recent years in English publications and, more extensively, from data published in Chinese language journals.The scoping review update was based on an earlier scoping review and included Chinese language publication data from China National Knowledge Internet (CNKI), WANFANG and WEIPU between January 2013 and May 2022 and data from PubMed, PsycINFO, and Cochrane Library between June 2020 and May 2022.Initially, 2 984 articles were identified, of which 63 full texts were included for analysis. In China, SSD is mainly applied in scientific research, but it also shows good predictive validity and clinical application potential. The mean frequency of SSD was 4.5% in the general population, 25.2% in the primary care population and 33.5% in diverse specialised care settings. Biological factors, such as brain region changes and heart rate variability, are associated with the onset of SSD. Psychological impairment related to somatic symptoms is the best predictor of prognosis. While adolescent SSD was significantly associated with family function, SSD overall is associated with an increased dysfunction of cognition and emotion, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Further research is needed on suicide risk and cultural and gender-related issues.Updating the data of Chinese language studies, our research enriches the evidence-based findings related to the topics addressed in the text sections of the SSD chapter of DSM-5. However, research gaps remain about SSD reliability, population-based prevalence, suicide risk, and cultural and gender-related issues.https://gpsych.bmj.com/content/36/3/e100942.full |
| spellingShingle | Zheng Lu Heng Wu Ayinuer Manglike Yixiao Chen Ziming Liu Kurt Fritzsche Scoping review update on somatic symptom disorder that includes additional Chinese data General Psychiatry |
| title | Scoping review update on somatic symptom disorder that includes additional Chinese data |
| title_full | Scoping review update on somatic symptom disorder that includes additional Chinese data |
| title_fullStr | Scoping review update on somatic symptom disorder that includes additional Chinese data |
| title_full_unstemmed | Scoping review update on somatic symptom disorder that includes additional Chinese data |
| title_short | Scoping review update on somatic symptom disorder that includes additional Chinese data |
| title_sort | scoping review update on somatic symptom disorder that includes additional chinese data |
| url | https://gpsych.bmj.com/content/36/3/e100942.full |
| work_keys_str_mv | AT zhenglu scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata AT hengwu scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata AT ayinuermanglike scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata AT yixiaochen scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata AT zimingliu scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata AT kurtfritzsche scopingreviewupdateonsomaticsymptomdisorderthatincludesadditionalchinesedata |